Urokinase-Type Plasminogen Activator Expression in Human Prostate Carcinomas

This publication has 16 references indexed in Scilit:

• Cancer statistics, 1996
  CA: A Cancer Journal for Clinicians, 1996
• Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer
  Cancer, 1994
• Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer
  Breast Cancer Research and Treatment, 1993
• The plasminogen‐activation system in ovarian tumors
  International Journal of Cancer, 1993
• Immunohistochemical Study of Tumor Cell-associated Plasminogen Activators and Plasminogen Activator Inhibitors in Lung Carcinomas
  Chest, 1993
• The plasminogen activator urokinase and its inhibitor PAI-2 in endometrial cancer
  Gynecologic Oncology, 1992
• Involvement of Urokinase and its Receptor in the Invasiveness of Human Prostatic Carcinoma Cell Lines
  Cancer Communications, 1991
• Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: Possible roles in tumor progression and metastasis
  Thrombosis Research, 1991
• Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer
  Fibrinolysis, 1990
• Plasminogen Activators in Human Prostate Cancer Cell Lines and Tumors: Correlation with the Aggressive Phenotype
  Journal of Urology, 1989